Khosrow Adeli Selected Research

Khosrow Adeli Research Topics

Disease

59	Insulin Resistance 11/2022 - 01/2002
43	Dyslipidemias (Dyslipidemia) 02/2024 - 03/2002
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017 - 09/2003
16	Obesity 01/2022 - 06/2007
16	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2002
14	Inflammation (Inflammations) 10/2023 - 03/2008
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 06/2006
13	Hypertriglyceridemia 09/2015 - 03/2002
9	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2002
8	COVID-19 01/2022 - 01/2020
7	Neoplasms (Cancer) 01/2023 - 12/2008
6	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 04/2002
5	Heart Failure 01/2023 - 02/2011
5	Fatty Liver 01/2018 - 12/2008
5	Hyperglycemia 01/2017 - 04/2002
5	Atherosclerosis 06/2012 - 06/2006
5	Hepatocellular Carcinoma (Hepatoma) 10/2008 - 02/2004
3	Myocarditis (Carditis) 10/2023 - 01/2021
3	Myocardial Infarction 01/2023 - 01/2018
3	Hemorrhage 02/2020 - 05/2005
3	Overweight 01/2020 - 11/2007
3	Glucose Intolerance 12/2017 - 08/2009
3	Weight Gain 09/2015 - 12/2004
3	Body Weight (Weight, Body) 12/2014 - 11/2009
3	Hypercholesterolemia 05/2012 - 10/2006
2	Congenital Heart Defects (Congenital Heart Defect) 01/2023 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 09/2015
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018 - 05/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2014 - 03/2011
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 06/2012 - 08/2007
2	Craniopharyngioma (Craniopharyngiomas) 08/2011 - 05/2010

Drug/Important Bio-Agent (IBA)

55	Insulin (Novolin)FDA Link 01/2022 - 01/2002
32	Lipoproteins (Lipoprotein)IBA 01/2020 - 03/2002
30	LipidsIBA 11/2022 - 11/2004
29	FructoseIBA 11/2020 - 01/2002
15	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2006
13	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2002
13	Apolipoproteins B (ApoB)IBA 08/2011 - 01/2002
11	VLDL LipoproteinsIBA 01/2018 - 01/2002
10	ChylomicronsIBA 10/2017 - 02/2007
10	ApolipoproteinsIBA 05/2010 - 01/2003
9	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2022 - 02/2013
8	CholesterolIBA 01/2021 - 08/2009
7	Apolipoprotein B-48IBA 10/2015 - 08/2002
6	AntigensIBA 01/2023 - 12/2014
5	TroponinIBA 10/2023 - 01/2021
5	Tyrosine (L-Tyrosine)FDA Link 03/2010 - 04/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 03/2002
4	Natriuretic PeptidesIBA 01/2023 - 02/2011
4	C-Reactive ProteinIBA 01/2022 - 03/2007
4	Messenger RNA (mRNA)IBA 12/2017 - 08/2009
4	HDL LipoproteinsIBA 09/2012 - 03/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 02/2007
4	HDL CholesterolIBA 08/2007 - 03/2002
4	Nonesterified Fatty Acids (NEFA)IBA 06/2006 - 04/2002
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 02/2011
3	Peptides (Polypeptides)IBA 01/2023 - 12/2014
3	EnzymesIBA 01/2022 - 01/2017
3	Dietary Fats (Dietary Fat)IBA 01/2020 - 08/2009
3	LDL Receptors (LDL Receptor)IBA 01/2018 - 09/2009
3	IncretinsIBA 07/2015 - 02/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2015 - 05/2005
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2014 - 03/2006
3	LeptinIBA 11/2010 - 11/2008
3	CytokinesIBA 09/2009 - 02/2007
3	Insulin ReceptorIBA 08/2009 - 04/2002
3	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009 - 01/2002
3	Rosiglitazone (Avandia)FDA Link 01/2005 - 08/2002
2	Hormones (Hormone)IBA 01/2023 - 12/2014
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 01/2018
2	trans-crotonin (CTN)IBA 01/2023 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2021
2	Ferritins (Ferritin)IBA 01/2022 - 01/2018
2	AntibodiesIBA 12/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2020
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 12/2014
2	Exenatide (Byetta)FDA Link 01/2020 - 12/2014
2	Glucagon-Like Peptide-2 ReceptorIBA 01/2019 - 01/2018
2	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2019 - 07/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2010
2	Apolipoproteins AIBA 01/2018 - 11/2007
2	Testosterone (Sustanon)FDA Link 01/2018 - 07/2014
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 12/2014
2	VitaminsIBA 01/2018 - 06/2014
2	Sterol Regulatory Element Binding Protein 1IBA 12/2017 - 05/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 08/2013
2	CarbohydratesIBA 12/2014 - 06/2006
2	SterolsIBA 01/2013 - 05/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2012 - 03/2002
2	GhrelinIBA 08/2011 - 11/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 04/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2010 - 05/2005
2	AdipokinesIBA 05/2010 - 09/2009

Therapy/Procedure

10	Therapeutics 10/2022 - 04/2006
2	Personal Protective Equipment 12/2020 - 01/2020